日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Divergent role of Mitochondrial Amidoxime Reducing Component 1 (MARC1) in human and mouse

线粒体酰胺肟还原成分 1 (MARC1) 在人类和小鼠中的不同作用

Eriks Smagris, Lisa M Shihanian, Ivory J Mintah, Parnian Bigdelou, Yuliya Livson, Heather Brown, Niek Verweij, Charleen Hunt, Reid O'Brien Johnson, Tyler J Greer, Suzanne A Hartford, George Hindy, Luanluan Sun, Jonas B Nielsen, Gabor Halasz, Luca A Lotta, Andrew J Murphy, Mark W Sleeman, Viktoria Gu

Hepatic TM6SF2 Is Required for Lipidation of VLDL in a Pre-Golgi Compartment in Mice and Rats

肝脏 TM6SF2 是小鼠和大鼠前高尔基区室中 VLDL 脂质化所必需的

Fei Luo, Eriks Smagris, Sarah A Martin, Goncalo Vale, Jeffrey G McDonald, Justin A Fletcher, Shawn C Burgess, Helen H Hobbs, Jonathan C Cohen

Relationship between genetic variation at PPP1R3B and levels of liver glycogen and triglyceride

PPP1R3B基因变异与肝糖原和甘油三酯水平的关系

Stender, Stefan; Smagris, Eriks; Lauridsen, Bo K; Kofoed, Klaus F; Nordestgaard, Børge G; Tybjaerg-Hansen, Anne; Pennacchio, Len A; Dickel, Diane E; Cohen, Jonathan C; Hobbs, Helen H

The PNPLA3 variant associated with fatty liver disease (I148M) accumulates on lipid droplets by evading ubiquitylation

与脂肪肝相关的 PNPLA3 变体 (I148M) 通过逃避泛素化而积聚在脂滴上

Soumik BasuRay, Eriks Smagris, Jonathan C Cohen, Helen H Hobbs

Inactivation of Tm6sf2, a Gene Defective in Fatty Liver Disease, Impairs Lipidation but Not Secretion of Very Low Density Lipoproteins

Tm6sf2 基因失活(脂肪肝疾病中的一种缺陷基因)会损害脂质形成,但不会影响极低密度脂蛋白的分泌

Eriks Smagris, Shenise Gilyard, Soumik BasuRay, Jonathan C Cohen, Helen H Hobbs

Pnpla3I148M knockin mice accumulate PNPLA3 on lipid droplets and develop hepatic steatosis

Pnpla3I148M敲入小鼠的脂滴上PNPLA3积累,并发生肝脂肪变性。

Smagris, Eriks; BasuRay, Soumik; Li, John; Huang, Yongcheng; Lai, Ka-man V; Gromada, Jesper; Cohen, Jonathan C; Hobbs, Helen H